FDA Approved Medical Products for:

Acromegaly

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Octreotide
Trade Name
(Manufacturer Name)
Sandostatin LAR
(Novartis Pharmaceuticals Corporation)
Indication
The FDA has approved this product to be used in this manner.
Reduction of growth hormone and IGF-1 (somatomedin C) in acromegaly.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Lanreotide
Trade Name
(Manufacturer Name)
Somatuline® Depot (injection)
(Tercica)
Indication
The FDA has approved this product to be used in this manner.
Long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy
More Information about this product Drug Information Portal

Generic Name Pegvisomant
Trade Name
(Manufacturer Name)
Somavert®
(Pfizer)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acromegaly in patients who have had an inadequate response to surgery and/or radiation therapy and/or other medical therapies, or for whom these therapies are not appropriate
More Information about this product Drug Information Portal